Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
25,830,741
-
Share change
-
-877,414
-
Total reported value
-
$2,040,642,641
-
Put/Call ratio
-
700%
-
Price per share
-
$79.11
-
Number of holders
-
164
-
Value change
-
-$65,425,616
-
Number of buys
-
86
-
Number of sells
-
44
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2025
As of 31 Dec 2025,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,830,741 shares.
The largest 10 holders included
VANGUARD GROUP INC, Tweedy, Browne Co LLC, Pictet Asset Management Holding SA, UBS Group AG, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, PINNACLE ASSOCIATES LTD, TEACHER RETIREMENT SYSTEM OF TEXAS, C WorldWide Group Holding A/S, Privium Fund Management B.V., and Universal- Beteiligungs- und Servicegesellschaft mbH.
This page lists
164
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.